CompaniesKeystone Nano

Keystone Nano

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

26

By Phase

PHASE1: 2

By Status

ENROLLING_BY_INVITATION: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT02834611
NCT04716452
Hover over trial bars to see details

Recent Trials

NCT04716452Lead Sponsor
Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
PHASE1Enrolling by invitation
12 participants
Started: Oct 1, 2025 · Completed: Oct 1, 2027
NCT02834611Lead Sponsor
Ceramide NanoLiposome in Patients With Advanced Solid Tumors
PHASE1Completed
14 participants
Started: Mar 15, 2017 · Completed: Nov 1, 2023